← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:101 | 101 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aluminum Hydroxide; Magnesium Hydroxide; Lidocaine Hydrochloride; Diphenhydramine Hydrochloride; Dimethicone | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:101 | 101 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-636 | 72833-636-30 | Arginine Hydrochloride; Propylparaben; Methylparaben | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:101 | 101 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-690 | 72833-690-50 | Ascorbic Acid | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-173 | 70092-173-43 | Atropine Sulfate | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-2 | Atropine Sulfate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5021 | 26436-5021-3 | Arginine | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:101 | 101 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6638 | 71300-6638-2 | Baclofen | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5429 | 26436-5429-2 | Benzocaine; Tetracaine; Lidocaine | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6705 | 71300-6705-4 | Baclofen | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:101 | 101 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6705 | 71300-6705-4 | Baclofen | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:102 | 102 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:102 | 102 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amino Acids | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:102 | 102 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:102 | 102 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine; Leucine; Tryptophan; Glycine; Isoleucine; Threonine; Methionine; Lysine; Valine; Phenylalanine; Histidine; Alanine; Proline; Serine; Tyrosine | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:102 | 102 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:102 | 102 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:102 | 102 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid; Tretinoin; Hyaluronic Acid | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:102 | 102 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:102 | 102 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:102 | 102 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5593 | 26436-5593-3 | Arginine Hydrochloride; Carnitine; Glutamine | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:102 | 102 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0001 | 72196-0001-1 | Aspartic Acid; Glutamic Acid | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:102 | 102 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6638 | 71300-6638-4 | Baclofen | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:102 | 102 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:102 | 102 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-3 | Benzocaine; Tetracaine; Lidocaine | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:102 | 102 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5538 | 72934-5538-5 | Benzocaine; Lidocaine; Tetracaine | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:102 | 102 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2539 | 72934-2539-4 | Benzocaine; Lidocaine; Tetracaine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:103 | 103 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69761-372 | 69761-372-01 | Testosterone / Stearic Acid | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:103 | 103 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aminobenzoic Acid | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:103 | 103 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:103 | 103 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:103 | 103 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:103 | 103 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-971 | 70731-971-10 | Ascorbic Acid; Glutathione | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:103 | 103 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aspartic Acid; Arginine | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:103 | 103 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:103 | 103 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-137 | 73198-137-03 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:103 | 103 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2442 | 72627-2442-1 | Arginine Hydrochloride; Citrulline | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:103 | 103 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0014 | 72196-0014-2 | Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:103 | 103 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:103 | 103 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1335 | 72934-1335-2 | Benzoyl Peroxide; Adapalene; Niacinamide | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:103 | 103 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:103 | 103 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5538 | 72934-5538-4 | Benzocaine; Lidocaine; Tetracaine | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:103 | 103 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5538 | 72934-5538-4 | Benzocaine; Lidocaine; Tetracaine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:104 | 104 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-7060 | 72196-7060-1 | Vancomycin 1.75gm added to NS | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1367 | 5446-1367-01 | Aminohippurate Sodium | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:104 | 104 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Anastrozole; Testosterone | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-690 | 72833-690-50 | Ascorbic Acid | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:104 | 104 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-906 | 70731-906-30 | Ascorbic Acid; Glutathione | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:104 | 104 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-137 | 73198-137-10 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5576 | 26436-5576-3 | Arginine; Thiamine Hydrochloride; Riboflavin 5'-Phosphate Sodium; Niacinamide; Pyridoxine Hydrochloride; Carnitine; Inositol; Choline Chloride; Methionine | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:104 | 104 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:104 | 104 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine; Tetracaine | 2024-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-2:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1327 | 72934-1327-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5429 | 26436-5429-2 | Benzocaine; Tetracaine; Lidocaine | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2539 | 72934-2539-4 | Benzocaine; Lidocaine; Tetracaine | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:104 | 104 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-5538 | 72934-5538-5 | Benzocaine; Lidocaine; Tetracaine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:105 | 105 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-612 | 70092-612-44 | L.E.T. Gel 1.5 ml in 3 ml Top Syr | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:105 | 105 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:105 | 105 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:105 | 105 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-916 | 70731-916-50 | Ascorbic Acid | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:105 | 105 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Asparaginase | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0014 | 71285-0014-2 | Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:105 | 105 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-002 | 73198-002-03 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:105 | 105 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2406 | 72934-2406-4 | Benzocaine; Lidocaine; Tetracaine | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1326 | 72934-1326-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1585 | 72934-1585-2 | Benzoyl Peroxide; Adapalene; Niacinamide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5429 | 26436-5429-2 | Benzocaine; Tetracaine; Lidocaine | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:105 | 105 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-3 | Benzocaine; Tetracaine; Lidocaine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:106 | 106 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-6 | BLT | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:106 | 106 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:106 | 106 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:106 | 106 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-975 | 70731-975-50 | Ascorbic Acid | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:106 | 106 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atenolol | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:106 | 106 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-002 | 73198-002-10 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2405 | 72627-2405-1 | Ascorbic Acid | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:106 | 106 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1331 | 72934-1331-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1579 | 72934-1579-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:106 | 106 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5429 | 26436-5429-2 | Benzocaine; Tetracaine; Lidocaine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:107 | 107 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-127 | 73177-127-05 | Potassium Chloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:107 | 107 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:107 | 107 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:107 | 107 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-906 | 70731-906-30 | Ascorbic Acid; Glutathione | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0014 | 71285-0014-2 | Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:107 | 107 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atenolol | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:107 | 107 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-006 | 73198-006-10 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2404 | 72627-2404-1 | Ascorbic Acid | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:107 | 107 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2023-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2024-1:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-6 | Benzocaine; Tetracaine; Lidocaine | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1328 | 72934-1328-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1578 | 72934-1578-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-3 | Benzocaine; Tetracaine; Lidocaine | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:107 | 107 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-3 | Benzocaine; Tetracaine; Lidocaine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:108 | 108 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-015 | 73198-015-03 | RE-1 | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:108 | 108 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2414 | 72627-2414-1 | Arginine Hydrochloride | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:108 | 108 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2020-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-2:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-971 | 70731-971-10 | Ascorbic Acid; Glutathione | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:108 | 108 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atenolol | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-101 | 73702-101-32 | Atropine | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:108 | 108 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-006 | 73198-006-03 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:108 | 108 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9011 | 83826-9011-3 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5433 | 26436-5433-1 | Benzocaine; Tetracaine; Lidocaine | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1329 | 72934-1329-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1581 | 72934-1581-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-3 | Benzocaine; Tetracaine; Lidocaine | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:108 | 108 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5200 | 26436-5200-4 | Benzocaine; Tetracaine; Lidocaine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:109 | 109 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-3611 | 72934-3611-2 | Fervina | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:109 | 109 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:109 | 109 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Arginine Hydrochloride; Propylparaben; Methylparaben | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:109 | 109 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:109 | 109 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Asparaginase | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:109 | 109 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atenolol | 2021-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-2:109 | 109 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:109 | 109 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:109 | 109 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-138 | 73198-138-10 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:109 | 109 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:109 | 109 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-2 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:109 | 109 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:109 | 109 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1330 | 72934-1330-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:109 | 109 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1583 | 72934-1583-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:109 | 109 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:109 | 109 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5473 | 26436-5473-1 | Benzocaine; Tetracaine; Lidocaine | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:110 | 110 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73693-386 | 73693-386-01 | TESTOSTERONE 87.5 MG | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-153 | 68985-153-85 | Amiodarone Hydrochloride | 2019-1 | valid | 0 | 2026-10-13 | |
outsourcing:2019-2:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72918-1205 | 72918-1205-1 | Ascorbic Acid | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-916 | 70731-916-50 | Ascorbic Acid | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0001 | 71285-0001-1 | Aspartic Acid; Glutamic Acid | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-935 | 69374-935-03 | Atropine | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:110 | 110 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:110 | 110 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-138 | 73198-138-03 | Atropine Sulfate; Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:110 | 110 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1411 | 72934-1411-2 | Benzoyl Peroxide; Adapalene; Clindamycin Phosphate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1332 | 72934-1332-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1584 | 72934-1584-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1585 | 72934-1585-2 | Benzoyl Peroxide; Adapalene; Niacinamide | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:110 | 110 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1585 | 72934-1585-2 | Benzoyl Peroxide; Adapalene; Niacinamide | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:111 | 111 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-658 | 70092-658-44 | L.E.T. Solution 3 ml in 5 ml TS | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:111 | 111 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amiodarone Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71591-500 | 71591-500-50 | Ascorbic Acid | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2404 | 72627-2404-1 | Ascorbic Acid | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0001 | 72196-0001-1 | Aspartic Acid; Glutamic Acid | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0010 | 81483-0010-1 | Atropine | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:111 | 111 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Atropine Sulfate | 2021-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-1:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72833-707 | 72833-707-02 | Avexitide | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-079 | 73198-079-30 | Ascorbic Acid | 2023-1 | valid | 0 | 2026-10-13 | |
outsourcing:2023-2:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83826-9010 | 83826-9010-3 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1336 | 72934-1336-2 | Benzoyl Peroxide; Adapalene; Clindamycin Phosphate | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:111 | 111 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzyl Alcohol | 2024-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2025-1:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1580 | 72934-1580-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1579 | 72934-1579-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:111 | 111 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1579 | 72934-1579-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:112 | 112 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6110 | 71266-6110-2 | Semaglutide | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:112 | 112 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amitriptyline Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:112 | 112 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2019-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2020-1:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2405 | 72627-2405-1 | Ascorbic Acid | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0014 | 71285-0014-2 | Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Sodium Chloride; Sodium Gluconate; Sodium Acetate; Potassium Chloride; Magnesium Chloride | 2020-2 | valid | 0 | 2026-10-13 | |
outsourcing:2021-1:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-101 | 73702-101-32 | Atropine | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-2 | Atropine Sulfate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2022-1 | valid | 0 | 2026-10-13 | |
outsourcing:2022-2:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-2 | Benzyl Alcohol | 2022-2 | valid | 0 | 2026-10-13 | |
outsourcing:2023-1:112 | 112 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ascorbic Acid | 2023-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2023-2:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-229 | 70092-229-43 | Atropine Sulfate | 2023-2 | valid | 0 | 2026-10-13 | |
outsourcing:2024-1:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1335 | 72934-1335-2 | Benzoyl Peroxide; Adapalene; Niacinamide | 2024-1 | valid | 0 | 2026-10-13 | |
outsourcing:2024-2:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69852-216 | 69852-216-10 | Betamethasone Acetate; Betamethasone Sodium Phosphate | 2024-2 | valid | 0 | 2026-10-13 | |
outsourcing:2025-1:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1582 | 72934-1582-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide; Tretinoin | 2025-1 | valid | 0 | 2026-10-13 | |
outsourcing:2025-2:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1578 | 72934-1578-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2025-2 | valid | 0 | 2026-10-13 | |
outsourcing:2026-1:112 | 112 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1578 | 72934-1578-2 | Benzoyl Peroxide; Clindamycin Phosphate; Niacinamide | 2026-1 | valid | 0 | 2026-10-13 | |
compounder:113 | 113 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70168-5002 | 70168-5002-1 | Estradiol 12.5mg | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:113 | 113 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Amitriptyline Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2019-2:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2404 | 72627-2404-1 | Ascorbic Acid | 2019-2 | valid | 0 | 2026-10-13 | |
outsourcing:2020-1:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70731-975 | 70731-975-50 | Ascorbic Acid | 2020-1 | valid | 0 | 2026-10-13 | |
outsourcing:2020-2:113 | 113 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Aspirin | 2020-2 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2021-1:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71506-036 | 71506-036-01 | Atropine Sulfate | 2021-1 | valid | 0 | 2026-10-13 | |
outsourcing:2021-2:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-2010 | 71266-2010-1 | Atropine Sulfate | 2021-2 | valid | 0 | 2026-10-13 | |
outsourcing:2022-1:113 | 113 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-13 | |||
outsourcing:2022-2:113 | 113 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2601 | 72627-2601-3 | Benzyl Alcohol | 2022-2 | valid | 0 | 2026-10-13 |